v3.25.2
CONDENSED STATEMENTS OF CASH FLOWS (UNAUDITED) - USD ($)
 3 Months Ended 12 Months Ended
Mar. 31, 2025
Mar. 31, 2024
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities:        
Net income $ 2,992,795 $ 6,393,390 $ 25,986,159 $ 16,915,460
Adjustments to reconcile net income to net cash used in operating activities:        
Investment income earned on investments held in Trust Account (5,698,441) (6,848,902) (27,761,686) (18,038,352)
Changes in operating assets and liabilities:        
Prepaid expenses 35,366 41,252 384,287 (508,750)
Accrued expenses 2,343,906 137,480 418,715 271,633
Due to related party 8,369 15,000 42,721 7,500
Net cash used in operating activities (318,005) (261,780) (929,804) (1,352,509)
Cash flows from investing activities:        
Cash deposited in Trust Account     0 (505,000,000)
Net cash used in investing activities     0 (505,000,000)
Cash flows from financing activities:        
Proceeds received from initial public offering, gross     0 500,000,000
Proceeds received from sale of private placement warrants     0 14,300,000
Proceeds received from overfunding loans     0 5,000,000
Repayment of promissory note     0 (366,781)
Payment of underwriter and advisory fee     0 (10,000,000)
Payment of offering costs     0 (675,587)
Net cash provided by financing activities     0 508,257,632
Net change in cash (318,005) (261,780) (929,804) 1,905,123
Cash – beginning of period 975,319 1,905,123 1,905,123 0
Cash – end of period $ 657,314 $ 1,643,343 975,319 1,905,123
Supplemental Cash Flow Information [Abstract]        
Offering costs included in accrued expenses     0 (270,391)
Deferred offering costs paid by Sponsor through promissory note     0 133,538
Deferred underwriting and advisory fees     $ 0 $ 17,500,000